Press Releases
All Releases
View Summary Enzon's CEO Signs a New Employment Agreement
Aug 11, 2000
 
View Summary Enzon Announces Schering-Plough's PEGINTRON™ Approved for Treatment of Hepatitis C in European Union
May 30, 2000
 
View Summary Schering-Plough Reports Results of Phase II PEG-INTRON™ Plus Ribavirin Studies at European Association for the Study of the Liver (EASL) Meeting
May 1, 2000
 
View Summary Phase III Clinical Trial Results Reported for PEG-INTRON® for the Treatment of Hepatitis C
Apr 18, 2000
 
View Summary Enzon, Inc. Raises an Additional $12.5 Million Through Exercise of Over-Allotment Option
Mar 24, 2000
 
View Summary Enzon, Inc. Prices Public Offering of 2 Million Shares of Common Stock at $44.50 per Share
Mar 21, 2000
 
View Summary Enzon Announces Award in Arbitration with Yoshitomi for Recombinant HSA
Feb 23, 2000
 
View Summary Enzon Announces Schering-Plough's PEGINTRON Recommended for Approval for Treatment of Hepatitis C in European Union (EU)
Feb 22, 2000
 
View Summary Enzon Announces Public Offering
Feb 22, 2000
 
View Summary Enzon Reports Schering-Plough's PEG-INTRON Accepted by the FDA for Review
Feb 10, 2000
 
View Summary Enzon Announces Schering-Plough Submits U.S. Application for PEG-INTRON for the Treatment of Chronic Hepatitis C
Jan 5, 2000
 
Showing 321-331 of 331 Page: 1 ... 13 14 15 16 17  Previous 20
Add to Briefcase = add release to Briefcase